SCHEMBL29409971

SCHEMBL29409971

CC(=O)/C(=N/O)C(=O)Nc1cccc(C(C)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ TP53 P04637 1/20 0.45
▸ GFER P55789 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ ACSS2 Q9NR19 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TOP2A P11388 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22678605 1.00 ALDH1A1 (0.47) ALDH1A1TP53GFERMAPTHTT
SCHEMBL24028391 0.90 ALDH1A1 (0.58) ALDH1A1TP53MAPTHTTRAB9A
SCHEMBL24027994 0.90 ALDH1A1 (0.58) ALDH1A1TP53MAPTHTTRAB9A
SCHEMBL22658193 0.86 ALDH1A1 (0.47) ALDH1A1TP53GFERMAPTHTT
SCHEMBL22658194 0.86 ALDH1A1 (0.47) ALDH1A1TP53GFERMAPTHTT
SCHEMBL29409968 0.86 ALDH1A1 (0.47) ALDH1A1TP53GFERMAPTHTT
SCHEMBL24028135 0.84 ALDH1A1 (0.43) ALDH1A1TP53GFERMAPTHTT
SCHEMBL30213098 0.84 ALDH1A1 (0.43) ALDH1A1TP53GFERMAPTHTT
SCHEMBL24027845 0.83 LMNA (0.46) ALDH1A1TP53GFERMAPTHTT
SCHEMBL30255658 0.83 LMNA (0.46) ALDH1A1TP53GFERMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149928-A1 IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2023-03-22 — — EP disclosed
EP-3969439-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-03-23 — — EP disclosed
Send feedback